A Cancer Researcher's Final Legacy: Brain Tumor Study Continues

Richard Scolyer, a leading cancer researcher, died in 2026 at 59 from glioblastoma—a deadly brain tumor. Before his death, he designed an experimental treatment using insights from his melanoma work. He became the first brain cancer patient to receive this personalized therapy before surgery. The clinical trial based on his approach now continues in the U.S., testing whether his breakthrough ideas can help other glioblastoma patients.